Rebecca Leyland

2PUBLICATIONS
4CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 05, 2021
Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity.

James Harper, Shannon Burke, Jon Travers

|May 18, 2019
MicroRNA-155 is essential for the optimal proliferation and survival of plasmablast B cells.

Giuseppina Arbore, Tom Henley, Laura Biggins

Pageof 1